Lonza, through its Bioscience Division, and Sanquin Reagents, have entered a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test (MAT). This partnership expands Lonza’s portfolio of endotoxin testing products, and enables drug developers and quality control (QC) labs to explore the full potential of the high-performing, sustainable MAT method to bring safe pharm...